Carly Bramel, PA
Physician Assistant · Hoover, ALNPI 1174061980
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,460 of the $4,004 with a category attached, or 61.4%. Sanofi accounts for 85.6% of it on its own, with 12 other manufacturers making up the rest. 2025 is the largest year on record at $3,536, more than ten times the $272 reported in 2021.
Across 30 payments — averaging $133.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$3K
- Regeneron Healthcare Solutions, Inc.$171
- AbbVie$96
- CSL Behring$58
- Amgen$48
- Optinose US, Inc.$45
- plus $158 from 7 others
What the payments were for
- Consulting fees$2,46061%
- Travel & lodging$71218%
- Food & beverage$79920%
- Education$341%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 7 | $3,429 |
| Regeneron Healthcare Solutions, Inc. | 3 | $171 |
| AbbVie(2 entities) | 6 | $96 |
| CSL Behring | 2 | $58 |
| Amgen | 2 | $48 |
| Optinose US, Inc. | 2 | $45 |
| Mauna Kea Technologies, Inc. | 1 | $39 |
| Novo Nordisk | 2 | $29 |
| Melinta Therapeutics, LLC | 1 | $26 |
| Amarin Pharma, Inc. | 1 | $21 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
| Avanir Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$4,004 in reported general payments places this provider in the 85th percentile of 846 physician assistant providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 13 | $46,365 |
| Ipratropium Bromide | 114 | $5,306 |
| Fluticasone Propionate | 155 | $2,002 |
| Azelastine Hcl | 24 | $1,043 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 32 | $645 |
| Acetazolamide | 11 | $482 |
| Methylprednisolone | 21 | $210 |
| Ciprofloxacin Hcl | 12 | $189 |
| Montelukast Sodium | 15 | $133 |
| Mupirocin | 17 | $126 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 16 | $125 |
| Prednisone | 12 | $44 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Hoover
- Elizabeth SmithHoover$11K
- Ashley PrichardHoover$11K
- Eleanor BurkeHoover$10K
- Natalie GeorgeBirmingham$540K
- Lauren MillerAnniston$487K
- Brianna BarryEnterprise$29K
- Ashley PeaceMobile$27K
- Andrea WombleHuntsville$22K
- Valerie GoodwinBirmingham$21K
- Marlee BrunoDecatur$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.